What is Clenbuterol?

What is Clenbuterol?

Another one of the newer products that we’re offering to you for laboratory research purposes only, Clenbuterol is a β2 agonist that also goes by the names Dilaterol, Spiropent, and Ventiplumin.  Before you purchase our 100% pure, USA made Clenbuterol you should understand that almost all published tests and research performed up to this point have all been built around in-vitro laboratory research.  We urge that further testing stay confined to strictly controlled environments like state-of-the-art laboratories. This is not ready for backyard experimentation. Clenbuterol is not FDA approved for use in humans.

β2 (beta2) Agonist

Clenbuterol falls within that class of drugs that act on the beta2 adrenergic receptors.  This class is most frequently referred to as “β2 Agonists.” The beta2 adrenergic receptors, frequently abbreviated ADRB2, are receptors inside of cells that bind to epinephrine.  Epinephrine is the hormone that communicates with the body. Think of it as the signal caller or the traffic director. So, transitively, beta2 agonists dictate what shot calling is going on as well as when and where because it is a neurotransmitter.  Altering epinephrine levels using β2 agonists can yield some impressive and beneficial results, differing depending on the β2 agonist that is being manipulated or introduced into a system.

What does it do?

Remember, Clenbuterol is not approved to be prescribed to humans within the United States.  Drugs need to be reviewed and receive FDA approval before that can happen. Outside the United States, depending on what country you’re in, it isn’t rare for Clenbuterol to be the leading, active ingredient in asthma prescriptions or in prescriptions to help treat chronic obstructive pulmonary disease.  COPD is typically treated in the United States with a variety of steroid based medications. While Clenbuterol isn’t a steroid, they share similar properties.

Right now in the United States, the FDA has approved Clenbuterol to be used on livestock.  Farmers are prescribed Clenbuterol based medications for horses, cattle, and swine that struggle with airway obstruction due to illness.

Adverse Effects of Clenbuterol – Both Human and Animal

Humans tend to experience chest pain, tremors, and a high rate of anxiety.  Side effects that both humans and animals have been known to experience include an increased heart rate, rapid breathing, heart palpitations, and an electrolyte imbalance.  Butchered cattle have been known to have remnants of that substance in their meat. If not removed, humans have reported sickness from ingestion of the affected meat.

Fatty Weight Loss and Muscle Mass Gains

Bodybuilders outside of the United States have been known to use Clenbuterol based products as a type of performance enhancer.  Found to be undeniably effective, over-supplementation can actually be fatal.  For almost thirty years, studies have proven that Clenbuterol increases fat burn, at least in lab rats.  More recent studies show that extended Clenbuterol use increases lean muscle mass, even if it doesn’t enhance athletic performance or endurance.  That doesn’t much matter in bodybuilding so it’s no wonder people have come to illegally dose.  Perhaps one day there will be a perfected Clenbuterol medication that doesn’t have the potentially lethal side effects.

Buy Clenbuterol Now

Reference:

1. Spiller, H A, et al. “A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, 2013, www.ncbi.nlm.nih.gov/pubmed/23844963.
2. Chance, W T, et al. “Clenbuterol Decreases Catabolism and Increases Hypermetabolism in Burned Rats.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Mar. 1991, www.ncbi.nlm.nih.gov/pubmed/2002523.
3. Kamalakkannan, G, et al. “Clenbuterol Increases Lean Muscle Mass but Not Endurance in Patients with Chronic Heart Failure.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Apr. 2008, www.ncbi.nlm.nih.gov/pubmed/18374884.